Screener
UroGen Pharma URGN Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from UroGen Pharma’s reported figures.
Based on trailing twelve months.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
FAQ
- What is UroGen Pharma's asset turnover?
- UroGen Pharma (URGN) reported asset turnover of 0.8× in Q2 2026.
- How has UroGen Pharma's asset turnover changed year-over-year?
- UroGen Pharma's asset turnover increased by 113.0% year-over-year, from 0.4× to 0.8×.
- What is the long-term trend for UroGen Pharma's asset turnover?
- Over 5 years (2020 to 2025), UroGen Pharma's asset turnover has grown at a 44.1% compound annual growth rate (CAGR), from 0.1× to 0.5×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about UroGen Pharma's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude